ONE-WAYOngoing theme · still written in the latest filings

Expansion of Steboronin’s indications to recurrent meningioma and angiosarcoma

An individual pharmaceutical development and regulatory approval theme concerning the expansion of Steboronin’s indications in Japan to recurrent meningioma and angiosarcoma, with the aim of strengthening the business foundation.

Companies1How many companies write about this.

Threads1One company can carry more than one thread here.

PeriodFY2021 →Still being written about.

Directionhelps1 helps · 0 hurts · 0 flat